A Comprehensive Guide to Pancreatic Cancer

About Pancreatic Cancer

Pancreatic cancer, characterized by a complex pathophysiology and late detection, presents significant treatment challenges. Often diagnosed at an advanced stage, the standard care includes surgery (if the tumor is confined to the pancreas), followed by chemotherapy and possibly radiation. The advent of specialized immunotherapies marks a promising direction in the treatment of pancreatic cancer.


The symptoms of pancreatic cancer are often subtle, manifesting as jaundice, persistent stomach to back pain, unexplained weight loss, fatigue, and weakness. Early detection is rare, with symptoms gradually developing over several months or years.


Diagnosis is typically late due to the gradual onset of symptoms. Various imaging techniques, including ultrasound, CT scans, and MRI, are employed to confirm the diagnosis and assess the extent of the disease.

Conventional Treatments

Treatment strategies are contingent upon the patient’s overall health and the stage of the cancer. Options include surgery (with procedures varying based on the tumor’s location within the pancreas), radiation therapy, and chemotherapy, often combined to enhance the treatment’s efficacy.

Integrative Medicine for Pancreatic Cancer

To complement conventional treatments, the following integrative therapies can be considered:

  • Autologous Immunotherapy: Utilizes the patient’s immune cells to target and eliminate cancer cells, potentially enhancing the body’s defense mechanisms against pancreatic cancer.
  • Pharmacological Immunotherapy: Involves the use of drugs to stimulate the immune system’s ability to combat pancreatic cancer cells, offering a targeted approach to cancer treatment.
  • Dendritic Enhancers: Enhance the function of dendritic cells, which play a crucial role in initiating immune responses against cancer cells, potentially amplifying the immune response against pancreatic cancer.
  • Systemic Perfusion Hyperthermia: A technique that uses heat to increase the susceptibility of pancreatic cancer cells to other treatments, potentially enhancing the effectiveness of primary therapies.
  • Mistletoe: Utilized as a complementary therapy, mistletoe can potentially improve symptoms and enhance the quality of life in pancreatic cancer patients.
  • Glutathione: A potent antioxidant that may protect cells from damage, potentially playing a protective role in pancreatic cancer treatment.
  • Personalized Nutrition: Tailoring nutrition plans to the individual needs of the patient, supporting overall health and well-being during pancreatic cancer treatment.
  • Vitamin D IV: Administered intravenously, it may enhance the immune response and have protective effects against pancreatic cancer.
  • Zinc: An essential mineral that plays a role in immune function and may help in improving the response to pancreatic cancer treatment.
  • Melatonin: A hormone that can help in managing sleep disturbances in pancreatic cancer patients, enhancing the quality of life.
  • Curcumin: A compound found in turmeric, it has anti-inflammatory and antioxidant properties, potentially offering protective effects against pancreatic cancer.
  • Sylimarin: A compound found in milk thistle, it has antioxidant properties and may help in protecting liver function during pancreatic cancer treatment.
  • Vitamin E: A potent antioxidant that helps in protecting cells from damage, supporting overall health during pancreatic cancer treatment.

By incorporating these integrative therapies, patients with pancreatic cancer can potentially benefit from a more comprehensive approach to cancer care, which may enhance the effectiveness of conventional treatments and improve the quality of life


The goal of cancer immunotherapy is to improve the body’s natural ability to find and destroy cancer cells. Successful immunotherapeutic approaches stimulate the natural defenses of the immune system and provide new ways to attack cancer. This is possible with comprehensive interventions that include cell therapy / immuno-pharmacological therapy in combination with nutritional, endocrine measures and supplements.

Dendritic enhancer or T-cell modulators

T-cell Modulators are peptide chains composed of tens of amino acids that appear to store all the experience of the immune system. The great intellectual leap to understand is that T-cell Modulators do not transfer antibodies nor create them directly, but its function is to educate, and teach the immune cells to recognize specific antigens that could happen to them unnoticed i.e. Pancreatic malignant cells.

T-cell Modulators do not cure anything but work to make a “smarter” immune system so that it is the body itself eliminating disease. They are therefore vital in developing the strategies of the immune system against cancer.

T-cell Modulators contains several immunoactive components that have been shown to act synergistically in raising Dendritic and NK function and also effective as adjuvant therapy in Pancreatic cancer treatments, elevating dendritic and NK function as much as 250%.


Hyperthermia involves the use of heat to directly treat a tumor or increase the vulnerability of cancer cells to other forms of treatment, such as immunotherapy, B17, vitamin C, chemotherapy or radiotherapy.

Liposomal Mistletoe

Mistletoe helps fight tumor-induced immune suppression. Natural killer cells (NK) are a type of white blood cell that looks for and destroys Pancreatic cancer cells. Research has shown that NK cells can spontaneously recognize and kill a variety of Pancreatic cancer cells.

Mistletoe has been called a “biological response modifier” due to its ability to improve various aspects of immune function. Studies show that it activates natural killer cells, T cells, macrophages and monocytes. A special proprietary form of liposomal mistletoe created with nanotechnology has been created for use in our Pancreatic cancer treatment approach.


Glutathione is the most important antioxidant produced by your body and a master detoxifier of every cell in your body. It prevents cellular damage caused by free radicals and peroxides. Glutathione metabolism is able to play both protective and pathogenic roles. It is crucial in the removal and detoxification of carcinogens, and alterations in this pathway can have a profound effect on cell survival. However, by conferring resistance to a number of chemotherapeutic drugs, elevated levels of glutathione in tumor cells are able to protect such cells.

Personalized nutrition

A typical diet, characterized by dependence on animal products, refined carbohydrates and unhealthy fats such as processed vegetable oils, can promote an inflammatory environment in the body. A pro-inflammatory diet has been associated with an increased risk of Pancreatic cancer and an increased risk of death from Pancreatic cancer.

We custom-make a diet targeted to enhance the immune system’s ability to heal and provide our patients with the right nutrition for their current and long-term needs.

Vitamin D

Patients with higher vitamin D levels were significantly less likely to die from the disease (Mondul 2016). In another study, short-term supplementation with high-dose vitamin D for three to eight weeks lowered PSA levels (Wagner 2013). Pancreatic cancer patients have a high prevalence of vitamin D deficiency indicating the need for appropriate supplementation (Fisher 2009). Vitamin D3 has multiple protective effects against pancreatic cancer including anti-angiogenic, anti-metastatic, anti-inflammatory, and immunomodulatory effects (Hung Pham 2011; Bulathsinghala 2010).


Healthy pancreas cells accumulate zinc to accomplish their normal cellular functions. In contrast, prostate cancer cells have depleted zinc stores, which makes them less susceptible to cell death.


Melatonin, a hormone best known for its role in regulating sleep, is also emerging as a promising anti-cancer agent. Evidence to date has shown that melatonin can interfere with cancer initiation, progression, and metastasis. In a clinical study in which melatonin plus low-dose interleukin-2 (IL-2) was used to treat pancreatic cancer patients with a life expectancy of less than 6 months, a complete response was achieved in one pancreatic cancer patient, and a partial response in three others.

Immunotherapy with melatonin and IL-2 was a well-tolerated and effective therapy for almost all advanced cancer patients with solid tumors, including those who did not respond to IL-2 alone or to chemotherapy (Lissoni 1995).

Diseases Treated at Integrative Immunotherapy Institute

Adrenal Cancer
Anal Cancer
Appendix Cancer
Bile Duct Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Carcinoid Tumors
Cervical Cancer
Colorectal Cancer
Esophageal Cancer
Eye Cancer
Gallbladder Cancer
Gastrointestinal Stromal Tumors (GIST)
Head and Neck Cancer
Hodgkin Lymphoma
Intestinal Cancer

Kidney Cancer
Liver Cancer
Lung Cancer
Metastatic Squamous Neck Cancer
Multiple Myeloma
Non-Hodgkin Lymphoma (NHL)
Oral Cancer
Ovarian Cancer
Pancreatic Cancer
Penile Cancer
Primary Central Nervous System (CNS) Lymphoma
Prostate Cancer
Sinus Cancer
Skin Cancer

Small Intestine Cancer
Soft Tissue Sarcoma
Spinal Cancer
Squamous Cell Carcinoma
Stomach Cancer
Testicular Cancer
Throat Cancer
Thymoma / Thymic Carcinoma
Thyroid Cancer
Urethral Cancer
Uterine Cancer
Vaginal Cancer
Vulvar Cancer

Bacterial & Viral Infections
Hepatitis C
Lyme Disease

Addison’s Disease
Autoimmune Inner Ear Disease (AIED)
Celiac Disease

Crohn’s Disease Treatment in Mexico – Top Clinic
Cushing Syndrome
Graves’ Disease
Guillain-Barre Syndrome

Hemolytic Anemia

Alzheimer’s Disease
Hypertension (High Blood Pressure)
Parkinson’s Disease